We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRL
5301
CALL
DELISTED
Control4 Corporation
CTRL
$565K ﹤0.01%
19,000
+6,300
+50% +$196K
PJP icon
5302
Invesco Pharmaceuticals ETF
PJP
$498M
$564K ﹤0.01%
+8,788
New +$563K
THD icon
5303
PUT
iShares MSCI Thailand ETF
THD
$357M
$564K ﹤0.01%
+6,100
New +$543K
AMID
5304
DELISTED
American Midstream Partners, LP
AMID
$564K ﹤0.01%
+42,227
New +$555K
BHF icon
5305
PUT
Brighthouse Financial
BHF
$3.5B
$563K ﹤0.01%
+9,600
New +$568K
ERF
5306
CALL
DELISTED
Enerplus Corporation
ERF
$563K ﹤0.01%
57,500
+18,500
+47% +$169K
BRS
5307
CALL
DELISTED
Bristow Group, Inc.
BRS
$563K ﹤0.01%
41,800
+12,500
+43% +$148K
TXMD icon
5308
CALL
TherapeuticsMD
TXMD
$24M
$562K ﹤0.01%
1,860
+1,342
+259% +$374K
VREX icon
5309
CALL
Varex Imaging
VREX
$523M
$562K ﹤0.01%
14,000
+3,600
+35% +$129K
TLND
5310
DELISTED
Talend S.A. American Depositary Shares
TLND
$562K ﹤0.01%
15,002
APU
5311
DELISTED
AmeriGas Partners, L.P.
APU
$562K ﹤0.01%
+12,152
New +$547K
AWI icon
5312
Armstrong World Industries
AWI
$7.84B
$561K ﹤0.01%
9,269
-170,340
-95% -$9.38M
INSM icon
5313
PUT
Insmed
INSM
$28.6B
$561K ﹤0.01%
18,000
-28,100
-61% -$830K
TTC icon
5314
CALL
Toro Company
TTC
$9.49B
$561K ﹤0.01%
8,600
-1,700
-17% -$108K
CRR
5315
CALL
DELISTED
Carbo Ceramics Inc.
CRR
$561K ﹤0.01%
55,100
-64,600
-54% -$571K
BAP icon
5316
PUT
Credicorp
BAP
$30.7B
$560K ﹤0.01%
2,700
+700
+35% +$145K
CBT icon
5317
PUT
Cabot Corp
CBT
$4.52B
$560K ﹤0.01%
+9,100
New +$547K
ELF icon
5318
CALL
e.l.f. Beauty
ELF
$5.81B
$560K ﹤0.01%
25,100
-10,800
-30% -$230K
REMX icon
5319
CALL
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.26B
$560K ﹤0.01%
6,200
+2,300
+59% +$191K
LFC
5320
CALL
DELISTED
China Life Insurance Company Ltd.
LFC
$560K ﹤0.01%
35,900
+13,800
+62% +$224K
AIV
5321
CALL
Aimco
AIV
$383M
$559K ﹤0.01%
+96,087
New +$566K
AMX icon
5322
CALL
America Movil
AMX
$71.2B
$559K ﹤0.01%
32,600
+4,300
+15% +$75K
EDIT icon
5323
PUT
Editas Medicine
EDIT
$442M
$559K ﹤0.01%
18,200
+2,900
+19% +$73K
HRTX icon
5324
CALL
Heron Therapeutics
HRTX
$92.9M
$559K ﹤0.01%
30,900
+8,000
+35% +$130K
IYE icon
5325
CALL
iShares US Energy ETF
IYE
$1.7B
$559K ﹤0.01%
14,100
-8,500
-38% -$320K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.